Katarzyna Szepietowska

  • Citations Per Year
Learn More
BACKGROUND The first line drugs for treatment of non-valvular atrial fibrillation (AF) are non-vitamin K oral anticoagulants (NOACs), which are preferred over vitamin K antagonists (VKAs). There is(More)
  • 1